Literature summary for 4.4.1.9 extracted from

Takahashi, H.; Ishihara, T.; Hase, S.; Chiba, A.; Nakaho, K.; Arie, T.; Teraoka, T.; Iwata, M.; Tugane, T.; Shibata, D.; Takenaka, S.
Beta-cyanoalanine synthase as a molecular marker for induced resistance by fungal glycoprotein elicitor and commercial plant activators (2006), Phytopathology, 96, 908-916.

Search for more literature for 4.4.1.9

Activating Compound

Activating Compound	Comment	Organism	Structure
1-amino-cyclopropane-1-carboxylate	induces CAS expression	Solanum lycopersicum
3-allyloxy-1,2-benzisothiazole-1,1-dioxide	co-induction by cell wall protein with elicitin activity from Pythium oligandrum and 3-allyloxy-1,2-benzisothiazole-1,1-dioxide	Solanum lycopersicum
benzo(1,2,3)thiadiazole-7-carbothioic acid S-methyl ester	-	Solanum lycopersicum
additional information	induction of CAS expression by cell wall protein with elicitin activity from Pythium oligandrum, coincides with ethylene production and may be induced by it. No significant induction at 4 h by abiotic stresses like bovine serum albumin, NaCl, mechanical wounding, drought, heat shocks, osmotic stress by mannitol and glucose, and dark treatments. Only very low level of induction of expression by cold stress, no induction with either salicylic acid or methyl jasmonate, no up-regulation by synthetic chemical 2,6-dichloroisonicotinic acid	Solanum lycopersicum
validamycin A	-	Solanum lycopersicum

Application

Application	Comment	Organism
agriculture	CAS seems to be useful for screening possible novel plant activators for plant protection against pathogens	Solanum lycopersicum

Organism

Organism	UniProt	Comment	Textmining
Solanum lycopersicum	-	cv. Micro-Tom	-

Source Tissue

Source Tissue	Comment	Organism	Textmining
leaf	low level	Solanum lycopersicum	-
root	abundant	Solanum lycopersicum	-
stem	low level	Solanum lycopersicum	-

Synonyms

Synonyms	Comment	Organism
beta-cyanoalanine synthase	-	Solanum lycopersicum
CAS	-	Solanum lycopersicum

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)